REXR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
REXR is not a strong buy right now for a Beginner with a long-term focus, even with $50,000-$100,000 to invest. The stock is near short-term support and there is some improvement in momentum, but the larger setup is mixed: moving averages remain bearish, analyst views are split, hedge funds have been selling heavily, and there is no strong proprietary buy signal. I would not call this a clear buy today; the better call is to hold and wait for stronger confirmation.
Current price is 34.02, slightly below the previous close of 34.21, while the market was closed. Momentum is mixed: MACD histogram is positive and expanding, which supports near-term upside, but RSI_6 at 56.62 is only neutral. The moving average structure is still bearish with SMA_200 > SMA_20 > SMA_5, showing the broader trend is not yet fully reversed. Price is trading around the pivot level of 33.677 and just under resistance at R1 34.319, so the stock is close to a breakout area but not decisively above it. The short-term pattern estimate suggests only modest next-week upside.
["Scotiabank upgraded Rexford Industrial to Outperform and set a $36 target, saying most downside may already be priced in.", "Recent upgrades from Evercore ISI and Cantor Fitzgerald earlier in the year show some continued support from the analyst community.", "MACD is positive and expanding, which signals improving near-term momentum.", "Balance sheet and liquidity look strong based on the news summary: debt-to-equity around 0.4 and current ratio about 7.2.", "The company has a long-term track record of compounding returns since 2013."]
["JPMorgan downgraded the stock to Underweight and Raymond James initiated Underperform, both citing weak growth and refinancing concerns.", "Moving averages are still bearish, indicating the broader trend remains weak.", "Hedge funds are reported to be selling aggressively, with selling up sharply over the last quarter.", "Options flow is defensive, with put demand materially stronger than call demand.", "SoCal growth concerns remain a recurring issue in analyst commentary, and several firms have lowered targets."]
Latest quarter season data is not fully provided, but recent news suggests Rexford generated about $1.0 billion in revenue and approximately $212 million in net income, which is solid profitability. The balance sheet also appears strong versus peers, with low leverage and high current ratio. However, analysts still describe growth as challenged, with concerns around muted FFO growth and refinancing headwinds in coming years.
Analyst sentiment is mixed but leaning cautious. On the positive side, Scotiabank upgraded the stock to Outperform with a $36 target, arguing downside is mostly priced in. On the negative side, JPMorgan downgraded to Underweight and Raymond James started coverage with Underperform, both citing muted growth and future headwinds. Earlier in April, Evercore ISI and Cantor Fitzgerald were more constructive with Outperform/Overweight views and $40 targets, but later June coverage turned more defensive. Overall, Wall Street sees some value and balance-sheet strength, but is concerned about growth quality and future earnings momentum.
